Pharma

Your Article Summary

See Latest Articles

Annual General Meeting of Active Biotech AB
Active Biotech, 05/11/09

In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. In accordance with the Election Committee's proposal, the Board members Mats Arnhög, Klas Kärre, Magnhild Sandberg, Peter Sjöstrand and Peter Ström were re-elected. Tomas Nicolin was elected new member of the Board. Tomas Nicolin, born in 1954, holds a degree in business administration from the Stockholm School of Economics and MIT Sloan School. Tomas Nicolin has many years of experience of executive positions in the financial sector, most recently as President of the retirement pension insurance company Alecta and President of the Third AP Fund. The Meeting also resolved to re-elect Mats Arnhög as Chairman of the Board.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09

A flexible operational unit simplifies the use of disposable equipment and ushers in a new level of biomanufacturing
b3c newswire, 12/02/09

 See all of Biotechnology

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast
Cell Therapeutics, 12/02/09

Cardinal Health helps hospitals improve safety, workflow, cost containment at 44 ASHP Midyear Clinical Meeting and Exhibition
Cardinal Health, 12/02/09

Genmab to present at 21st annual piper jaffray health care conference
Genmab, 12/02/09

 See all of Conferences/Meetings